Stockscreener 앱 받기
7.43%
시장 영업 전:
전일 마감가:
$1.48
열려 있는:
$1.48
하루 거래량:
17.85M
Relative Volume:
1.19
시가총액:
$942.62M
수익:
$29.48M
순이익/손실:
$-201.19M
주가수익비율:
-4.9688
EPS:
-0.32
순현금흐름:
$-216.50M
1주 성능:
-6.47%
1개월 성능:
-9.66%
6개월 성능:
-64.19%
1년 성능:
-48.71%
1일 변동 폭
$1.45
$1.62
1주일 범위
$1.45
$1.735
52주 변동 폭
$1.45
$5.34
제론 Stock (GERN) Company Profile
명칭
Geron Corp
전화
(650) 473-7700
주소
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
GERN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
1.59 | 942.62M | 29.48M | -201.19M | -216.50M | -0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.49 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
625.60 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
583.62 | 35.60B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.83 | 34.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
274.78 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
제론 Stock (GERN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-27 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2025-02-26 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-11-05 | 개시 | H.C. Wainwright | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-09-09 | 개시 | Leerink Partners | Outperform |
| 2024-04-30 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-04-29 | 개시 | TD Cowen | Buy |
| 2024-03-15 | 재확인 | Needham | Buy |
| 2023-09-12 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-03-28 | 개시 | Goldman | Neutral |
| 2022-10-28 | 개시 | Wedbush | Outperform |
| 2022-07-28 | 재개 | B. Riley Securities | Buy |
| 2021-11-02 | 개시 | Robert W. Baird | Outperform |
| 2021-02-18 | 재개 | B. Riley Securities | Buy |
| 2020-08-03 | 개시 | Stifel | Buy |
| 2019-11-19 | 재개 | B. Riley FBR | Buy |
| 2019-09-03 | 개시 | H.C. Wainwright | Buy |
| 2019-08-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-04-09 | 업그레이드 | Needham | Hold → Buy |
| 2019-01-31 | 업그레이드 | B. Riley FBR | Neutral → Buy |
| 2018-10-02 | 다운그레이드 | B. Riley FBR | Buy → Neutral |
| 2018-07-05 | 개시 | B. Riley FBR, Inc. | Buy |
| 2016-09-13 | 재확인 | FBR & Co. | Outperform |
| 2016-09-13 | 재확인 | FBR Capital | Outperform |
| 2015-12-07 | 재확인 | Piper Jaffray | Overweight |
| 2015-04-21 | 개시 | Oppenheimer | Outperform |
| 2014-06-12 | 업그레이드 | MLV & Co | Hold → Buy |
| 2014-03-12 | 다운그레이드 | MLV & Co | Buy → Hold |
| 2013-12-10 | 재확인 | MLV & Co | Buy |
| 2013-12-10 | 업그레이드 | Needham | Hold → Buy |
| 2013-11-08 | 재확인 | MLV & Co | Buy |
| 2013-10-16 | 개시 | MLV & Co | Buy |
| 2012-08-30 | 개시 | Stifel Nicolaus | Buy |
| 2012-06-28 | 개시 | Needham | Hold |
모두보기
제론 주식(GERN)의 최신 뉴스
GERN INVESTOR DEADLINE: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
GERN INVESTOR ALERT: Kirby McInerney LLP Notifies Geron Corporation Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit - GlobeNewswire Inc.
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Geron stock touches 52-week low at $1.46 amid market challenges - Investing.com
GERN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Geron Corp.: A Compelling Potential Buying Opportunity Thanks To Bearish Comments (GERN) - Seeking Alpha
Geron Q1 2025 Earnings: Complete Coverage of May 7 Financial Results and Conference Call - Stock Titan
Geron Plans to Announce First Quarter 2025 Financial Results on May 7, 2025 - Yahoo Finance
Geron Corporation's (NASDAQ:GERN) Profit Outlook - simplywall.st
GERN Securities Lawsuit Filed Against Geron Corporation- Contact the DJS Law Group to Discuss Your Rights - PR Newswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron - The Malaysian Reserve
GERN INVESTOR ALERT: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
When Can We Expect A Profit From Geron Corporation (NASDAQ:GERN)? - Yahoo Finance
GERN Investors Have Opportunity to Lead Geron Corporation Securities Fraud Lawsuit - MarketScreener
GERN Investors Have Opportunity to Lead Geron Corporation Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
GERN Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Geron Corporation (GERN)Contact Kessler Topaz Meltzer & Check, LLP - Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against XPLR, Geron, enCore, and TFI and Encourages Investors to Contact the Firm - TradingView
Deep Track Capital, LP's Strategic Acquisition of Geron Corp Shares - GuruFocus
Is Geron Corporation (NASDAQ:GERN) The Top Penny Stock That Will Skyrocket? - Insider Monkey
Top 10 Penny Stocks That Will Skyrocket - Insider Monkey
GERN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
Class Action Filed Against Geron Corporation (GERN) Seeking Recovery for InvestorsContact The Gross Law Firm - PR Newswire
GERN INVESTOR NOTICE: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Eastern Progress
GERN INVESTOR NOTICE: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
Indo-Asian News Service - IANS India Pvt Ltd
Faruqi & Faruqi Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025GERN - PR Newswire
Geron Corporation Sued for Securities Law ViolationsContact Levi & Korsinsky Before May 12, 2025 to Discuss Your RightsGERN - PR Newswire
Geron reports inducement grants under Nasdaq listing rule 5635(C)(4) -March 19, 2025 at 04:43 pm EDT - Marketscreener.com
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron Grants 225,000 Shares in Stock Options and RSUs to Attract Key Talent - Stock Titan
Is Geron (GERN) Among the Most Oversold Penny Stocks to Buy According to Analysts? - Insider Monkey
Geron Corp: How Concerned Should We Be About Rytelo Sales? (NASDAQ:GERN) - Seeking Alpha
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron - Markets Insider
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Geron - GlobeNewswire
Rosen Law Firm Urges Geron Corporation (NASDAQ: GERN) Stockholders to Contact the Firm for Information About Their Rights - Business Wire
GERN ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Geron Corporation Investors - TradingView
GERN INVESTOR ALERT: Geron Corporation Investors with Substantia - GuruFocus.com
GERN INVESTOR ALERT: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve
GERN INVESTOR ALERT: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
HC Wainwright Reiterates Neutral Rating for Geron (NASDAQ:GERN) - Defense World
GERN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Investor Brings Securities Class Action Against Geron Corp. (1) - Bloomberg Tax
SBI Securities Co. Ltd. Acquires New Holdings in Geron Co. (NASDAQ:GERN) - Defense World
Geron’s SWOT analysis: biotech stock faces pivotal year for growth By Investing.com - Investing.com South Africa
Geron Corp appoints interim CEO amid leadership shuffle By Investing.com - Investing.com Australia
Geron Corp reveals CEO is leaving - The Pharma Letter
H.C. Wainwright holds neutral on Geron stock post-EU approval - Investing.com
H.C. Wainwright holds neutral on Geron stock post-EU approval By Investing.com - Investing.com South Africa
Geron’s SWOT analysis: biotech stock faces pivotal year for growth - Investing.com
Geron Co. (NASDAQ:GERN) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
제론 (GERN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.00%
자본화:
|
볼륨(24시간):